Condition
Central Nervous System Diseases clinical trials and research
As of November 12, 2026, Find a Trial lists 29 Central Nervous System Diseases clinical trials that are recruiting, at sites in 18 countries (most in United States (9), France (4), Germany (4)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 2/3 (1), Phase 1/2 (1), Phase 1 (1). The most active sponsors are Kessler Foundation (2), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2), Radboud University Medical Center (2). There are also 1 NIH-funded research project on Central Nervous System Diseases, with $192,590 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 29Clinical trials
- 1NIH research projects
- 1New in 30 days
- 18Countries
Newest Central Nervous System Diseases clinical trials
All recruiting trials (29)
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Selective activation of the adrenomedullin receptor to provoke migraine in adults with migraine without aura
This study tests whether selectively activating the adrenomedullin receptor can trigger migraine attacks in adults who have migraine without aura, after blocking CGRP receptors.
-
Silevertinib plus temozolomide for newly diagnosed GBM with unmethylated MGMT and EGFRvIII
This trial tests whether adding silevertinib to standard temozolomide helps people with newly diagnosed glioblastoma that have EGFRvIII and an unmethylated MGMT promoter live longer without the cancer getting worse.
-
Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders
This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).
-
Virtual reality plus bilateral brain stimulation to improve arm and hand recovery after stroke
We will try combining virtual reality exercises with bilateral transcranial direct current stimulation (bi‑tDCS) to improve arm and hand movement in adults at least three months after a unilateral stroke.
-
Slow-SPEED: Can a smartphone app help people with prodromal Parkinson's stay more active?
This trial tests whether a remote smartphone app can help people with a LRRK2 G2019S or GBA1 N370S mutation increase daily activity and see if exercise might slow prodromal Parkinson's signs.
-
Heart assessment to check repeat-stroke risk in people with atrial fibrillation
This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.
-
Portable EEG to triage suspected stroke patients in ambulances
This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.
-
Evaluating therapy for patients with minor strokes and large vessel occlusion
This study is testing different treatment options for patients with minor strokes caused by blocked large blood vessels to see which ones help them recover better.
-
Video call assessment for suspected stroke
This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.
-
Using PET/MRI to Monitor Brain Inflammation
This study is testing how PET/MRI scans can help track brain inflammation in people with conditions like stroke, autoimmune encephalitis, and multiple sclerosis.
-
Evaluating the impact of artery calcification on stroke treatment outcomes
This study is trying to see if the amount of calcium in the arteries affects how well stroke patients do after a specific treatment for blocked blood vessels.
-
Using deep brain stimulation to improve speech and arm function after stroke
This study is testing if deep brain stimulation can help improve hand movement and speech in people who have had a stroke.
-
Increasing physical activity in patients at risk of Parkinson's disease using a smartphone app
This study is testing a smartphone app to help people at risk of Parkinson's disease increase their physical activity and exercise intensity over two years.
-
Monitoring brain-derived tau levels in acute ischemic stroke patients
This study is testing how brain-derived tau levels change in stroke patients over 48 hours to see if it can help understand their condition and improve treatment decisions.
-
Evaluating a new treatment for cognitive function in mild Alzheimer's dementia
This study is testing a new treatment that combines brain stimulation and cognitive training to see if it can help people with mild Alzheimer's dementia improve their thinking skills.
-
Using virtual reality to help stroke patients walk again
This study tests whether using virtual reality during walking rehab can help stroke patients who can't walk feel more motivated and improve their walking ability compared to regular rehab methods.
-
Comparing awake and asleep deep brain stimulation for essential tremor
This study is testing whether deep brain stimulation done while patients are awake works better than when it's done while they're asleep for people with essential tremor who haven't found relief with medication.
-
Using virtual and mixed reality technology with mirror therapy for stroke rehabilitation
This study is testing new virtual and mixed reality therapies combined with mirror therapy to see if they can help stroke patients recover their movement better than traditional methods.
-
Intra-arterial tenecteplase given after thrombectomy for anterior large-vessel ischemic stroke with no-reflow or residual clot
This trial will test whether giving tenecteplase directly into the artery at the end of thrombectomy helps people with anterior large-vessel ischemic stroke treated within 24 hours of symptom onset.
-
Multi-domain lifestyle intervention for older adults at risk of cognitive decline in China
This study is testing a lifestyle program that includes exercise, healthy eating, brain training, and managing health risks to see if it can help older adults in China avoid memory problems and dementia.
-
Transcutaneous spinal stimulation to improve blood pressure after a recent spinal cord injury
We will try a noninvasive spinal stimulation to see if it raises and steadies blood pressure in people 7–30 days after a thoracic spinal cord injury who have low blood pressure or dizziness when sitting up.
-
Transcutaneous spinal stimulation to stabilize blood pressure after spinal cord injury
This will test whether noninvasive transcutaneous spinal cord stimulation can raise and stabilize blood pressure in people with chronic high-level spinal cord injuries who experience orthostatic hypotension.
-
Combination treatment for brain metastasis from ER+/HER-2- breast cancer
This study is testing a new combination treatment of elacestrant and abemaciclib to see if it can help people with brain metastases from estrogen receptor-positive, HER-2 negative breast cancer.
-
Analyzing Inflammatory Biomarkers for Diagnosing CNS Autoimmune Diseases
This study is testing if certain markers in blood and spinal fluid can help doctors more accurately diagnose multiple sclerosis and other similar brain conditions.
-
Combining testosterone therapy with walking training to improve health after spinal cord injury
This study is testing if combining testosterone therapy with walking training can help men with spinal cord injuries who have low testosterone and trouble walking improve their health and mobility.
-
Exploring Brain Connections for Arm Movement After Stroke
This study is testing how different parts of the brain work together to control arm movement before and after a stroke, to see if new stimulation methods can help stroke patients regain better use of their arms.
-
Using a virus therapy to treat recurrent cerebellar brain tumors in children
This study is testing a new virus treatment for children with recurring brain tumors to see if it can help them get better when combined with a low dose of radiation.
-
A smartphone app to help manage depression symptoms
This study is testing a smartphone app that helps people with depression track their symptoms and treatment to see if it can improve their care.
NIH-funded research (1)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Exploring tiny RNAs as potential markers for brain diseases linked to gammaherpesvirus.
This study is looking at tiny pieces of genetic material linked to the Epstein-Barr virus to see if they can help doctors diagnose brain-related issues in people with weakened immune systems, and patients may be asked to share samples to help with this research.
Related topics
Quick answers
How many Central Nervous System Diseases clinical trials are recruiting right now?
29, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in United States (9 trials), France (4 trials), Germany (4 trials), China (4 trials), Netherlands (4 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.